Part 3: Pharmacogenetic Variability in Phase II Anticancer Drug Metabolism

Equivalent drug doses may lead to wide interpatient variability in drug response to anticancer therapy. Known determinants that may affect the pharmacological response to a drug are, among others, nongenetic factors, including age, gender, use of comedication, and liver and renal function. Nonethele...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Deenen, Maarten J., Cats, Annemieke, Beijnen, Jos H., Schellens, Jan H.M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2011
Aiheet:
Clinical Pharmacology: Pharmacogenetics: Opportunities for Patient-Tailored Anticancer Therapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228134/
https://ncbi.nlm.nih.gov/pubmed/21659608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0260
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia